Edgewise Therapeutics (EWTX) Stock Highlights

15.52 | -22.9%

2025-04-03 03:42:45

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Statistics

Range Today

12.18 16.13

Volume Today 16.11M

Range 1 Year

14.9 38.12

Volume 1 Year 243.46M

Range 3 Year

5.12 38.12

Volume 3 Year 415.1M

Range 10 Year

5.12 40.49

Volume 10 Year 476.86M

Highlights

Market Capitalization 2.22B (mid)

Floating Shares 54.42M

Current Price 15.52

Price To Earnings -16.05

Price To Book 4.81

Earnings Per Share -1.45

Payout Ratio 0%

Performance

Latest -22.9%

1 Month -39.82%

3 Months -41.98%

6 Months -43.15%

1 Year -11.87%

3 Years +60.17%

5 Years -42.52%

10 Years -42.52%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.